Literature DB >> 19232362

Cilostazol and pentoxifylline decrease angiogenesis, inflammation, and fibrosis in sponge-induced intraperitoneal adhesion in mice.

Juliana Barros Mendes1, Paula Peixoto Campos, Monaliza Angela Rocha, Silvia Passos Andrade.   

Abstract

AIMS: Adhesion formation following abdominal intervention is an abnormal peritoneal healing process. Our aim was to investigate the effects of controlling adhesion development by inhibiting its key components (angiogenesis, inflammation and fibrosis) using phosphodiesterase (PDE) inhibitors. MAIN
METHODS: Two PDE inhibitors including cilostazol a PDE3 inhibitor (40 and 400 mg/kg), and pentoxifylline (PTX), a PDE 1-5 inhibitor (50 and 500 mg/kg) were used for a period of 7 days to inhibit angiogenesis, inflammation, and fibrosis in a murine model of sponge-induced peritoneal adhesion. Angiogenesis was assessed by hemoglobin content, vascular endothelial growth factor (VEGF) levels, and morphometric analysis. Accumulation of neutrophils and macrophages was determined by measuring myeloperoxidase (MPO) and N-acetylglucosaminidase (NAG) activities, respectively. Levels of TNF-alpha were also determined. Fibrosis was assessed by determining the amount of collagen in the implant; TGF-beta1 levels in the implant were also measured. KEY
FINDINGS: Our results show that the treatments attenuated the main components of the adhesion tissue by reducing the amount of fibrovascular tissue that infiltrated the sponge matrix (wet weight). Hemoglobin content and VEGF levels were also decreased by approximately 40%. Neutrophil accumulation was unaffected by the compounds. However, NAG activity was reduced by pentoxifylline, but not by cilostazol. These compounds also decreased the levels of the pro-inflammatory and pro-fibrogenic cytokines TNF-alpha and TGF-beta1, respectively, and collagen synthesis. SIGNIFICANCE: Our results suggest that cilostazol and PTX decreased the development of peritoneal adhesions in the model, which might be associated with cyclic nucleotide modulation. Therapies to intervene in these pathways may be beneficial for the prevention of these lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232362     DOI: 10.1016/j.lfs.2009.01.023

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  High-carbohydrate diet selectively induces tumor necrosis factor-α production in mice liver.

Authors:  Adaliene Versiani Matos Ferreira; Erica Guilhen Mario; Laura Cristina Jardim Porto; Silvia Passos Andrade; Leida Maria Botion
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

2.  Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis.

Authors:  Jennifer L Herington; Marta A Crispens; Alessandra C Carvalho-Macedo; Aroldo Fernando Camargos; Dan I Lebovic; Kaylon L Bruner-Tran; Kevin G Osteen
Journal:  Fertil Steril       Date:  2010-10-08       Impact factor: 7.329

Review 3.  Advances in the Pathogenesis of Adhesion Development: The Role of Oxidative Stress.

Authors:  Awoniyi O Awonuga; Jimmy Belotte; Suleiman Abuanzeh; Nicole M Fletcher; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

4.  The phosphodiesterase 3 inhibitor cilostazol does not stimulate growth of colorectal liver metastases after major hepatectomy.

Authors:  Moritz J Strowitzki; Stefan Dold; Maximilian von Heesen; Christina Körbel; Claudia Scheuer; Mohammed R Moussavian; Martin K Schilling; Otto Kollmar; Michael D Menger
Journal:  Clin Exp Metastasis       Date:  2014-07-23       Impact factor: 5.150

5.  Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model.

Authors:  Jennifer L Herington; Dana R Glore; John A Lucas; Kevin G Osteen; Kaylon L Bruner-Tran
Journal:  Fertil Steril       Date:  2012-10-25       Impact factor: 7.329

6.  Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model.

Authors:  Mamoudou Maiga; Nisheeth Agarwal; Nicole C Ammerman; Radhika Gupta; Haidan Guo; Marama C Maiga; Shichun Lun; William R Bishai
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

7.  Antifibrotic effects of pentoxifylline improve the efficacy of gemcitabine in human pancreatic tumor xenografts.

Authors:  Jung Ho Kim; Byung Cheol Shin; Won Sang Park; Jaehwi Lee; Hyo-Jeong Kuh
Journal:  Cancer Sci       Date:  2017-10-31       Impact factor: 6.716

8.  Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art.

Authors:  Clarice Zc Chen; Michael Raghunath
Journal:  Fibrogenesis Tissue Repair       Date:  2009-12-15

9.  Effects of pentoxifylline on renal structure after urethral obstruction in rat: A stereological study.

Authors:  Mehdi Shirazi; Ali Noorafshan; Amir Farrokhi
Journal:  Cent European J Urol       Date:  2011-03-18

10.  The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice.

Authors:  Barbara Joanna Bałan; Urszula Demkow; Piotr Skopiński; Małgorzata Bychawska; Ewa Skopińska-Różewska; Sławomir Lewicki; Robert Zdanowski
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.